check_circleStudy Completed

Pharmacokinetics

Pharmacokinetic study comparing Aspirin and Aspirin granules

Trial purpose

To determine the bioequivalence of new formula of aspirin relative to the established commercial aspirin plain tablet and aspirin dry granules when taken orally by healthy adult subjects

Key Participants Requirements

Sex

Both

Age

18 - 55 Years

Trial summary

Enrollment Goal
30
Trial Dates
July 2009 - August 2009
Phase
Phase 1
Could I Receive a placebo
No
Products
Bayer Advanced Aspirin (Acetylsalicylic acid, BAY1019036)
Accepts Healthy Volunteer
Yes

Where to participate

StatusInstitutionLocation
Completed
Frontage Laboratories, LLCHackensack, 07601, United States

Primary Outcome

  • Bioequivalence of new formula aspirin relative to the established commercial aspirin plain tablet and aspirin dry granules when taken orally by healthy adult subjects
    date_rangeTime Frame:
    24 hours
    enhanced_encryption
    Safety Issue:
    no

Secondary Outcome

  • To assess safety and tolerability of the new aspirin formula
    date_rangeTime Frame:
    24 hours
    enhanced_encryption
    Safety Issue:
    yes
  • To assess additional pharmacokinetic parameters
    date_rangeTime Frame:
    24 hours
    enhanced_encryption
    Safety Issue:
    no

Trial design

An Open Label Crossover Pharmacokinetic Trial of New Formula Aspirin versus Aspirin Tablets and Aspirin Dry Granules in Healthy Adult Subjects
Trial Type
Interventional
Intervention Type
Drug
Trial Purpose
Treatment
Allocation
Randomized
Blinding
Open Label
Assignment
Crossover Assignment
Trial Arms
4